Syed Kasmiri

Title: Syed Kasmiri: Innovator in Humanized Antibodies

Introduction

Syed Kasmiri is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. His work focuses on enhancing the efficacy and safety of these antibodies for medical applications.

Latest Patents

Syed Kasmiri holds 1 patent for his invention titled "Framework residue substituted humanized COL-1 antibodies and their use." This patent provides a detailed disclosure of humanized COL-1 monoclonal antibodies that maintain CEA binding affinity compared to a parent antibody. The invention also addresses the reduction of immunogenicity in these antibodies, making them more suitable for therapeutic use. The patent outlines methods for utilizing these humanized COL-1 antibodies in the detection or treatment of CEA-expressing tumors or cells in subjects. Additionally, it includes a kit featuring the described humanized COL-1 antibodies.

Career Highlights

Syed Kasmiri is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to contribute to groundbreaking research in the field of immunology and cancer treatment.

Collaborations

Some of his notable coworkers include Rafia Mehdi Kashmiri, who serves as a Legal Representative, and Jeffrey Schlom, who collaborates with him on various projects.

Conclusion

Syed Kasmiri's innovative work in the development of humanized antibodies represents a significant advancement in medical science. His contributions have the potential to improve cancer detection and treatment, showcasing the importance of innovation in healthcare.